Depressive Disorders - Guatemala | Statista Market Forecast

Revenue in the Depressive Disorders market is projected to reach US$21.46m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.80%, resulting in a market volume of US$24.64m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$25.37 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in Guatemala has been experiencing significant growth in recent years.

Customer preferences: Guatemalan consumers have become more aware of mental health issues and the importance of seeking treatment for depressive disorders. There is a growing demand for effective medications and therapies to manage and treat depression. Additionally, there is a preference for holistic approaches to mental health, including alternative therapies such as yoga and meditation.

Trends in the market: One of the key trends in the Depressive Disorders market in Guatemala is the increasing availability and accessibility of mental health services. There has been a rise in the number of mental health clinics and professionals offering specialized care for individuals with depressive disorders. This trend is driven by a combination of factors, including increased funding for mental health services, improved awareness and understanding of mental health issues, and a growing recognition of the impact of depression on overall well-being.Another trend in the market is the introduction of new medications and therapies for the treatment of depressive disorders. Pharmaceutical companies are investing in research and development to create innovative treatments that are more effective and have fewer side effects. These new treatments are being well-received by both healthcare professionals and patients, leading to increased demand and market growth.

Local special circumstances: Guatemala has a unique set of circumstances that contribute to the development of the Depressive Disorders market. The country has a high prevalence of poverty and inequality, which can contribute to the development of mental health issues such as depression. Additionally, Guatemala has a history of political instability and violence, which can also have a significant impact on mental health. These local special circumstances create a greater need for mental health services and contribute to the growth of the Depressive Disorders market.

Underlying macroeconomic factors: The growth of the Depressive Disorders market in Guatemala is also influenced by underlying macroeconomic factors. The country has experienced steady economic growth in recent years, which has led to an increase in disposable income and healthcare spending. As a result, more individuals are able to afford mental health services and medications for the treatment of depressive disorders. Additionally, the government has made efforts to improve access to healthcare services, including mental health services, which has further contributed to market growth.In conclusion, the Depressive Disorders market in Guatemala is developing due to increasing customer awareness and demand for mental health services, the introduction of new treatments, local special circumstances, and underlying macroeconomic factors. As the market continues to grow, it is important for healthcare providers and pharmaceutical companies to adapt to the changing needs and preferences of Guatemalan consumers.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.